Terumo (TRUMY)
(Delayed Data from OTC)
$19.21 USD
+0.25 (1.32%)
Updated Aug 27, 2024 03:51 PM ET
3-Hold of 5 3
C Value C Growth C Momentum D VGM
Income Statements
Fiscal Year end for Terumo Corp falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 6,386 | 6,070 | 6,259 | 5,770 | 5,786 |
Cost Of Goods | NA | 2,981 | 2,972 | 2,700 | 2,622 |
Gross Profit | NA | 3,089 | 3,287 | 3,070 | 3,164 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 2,220 | 2,255 | 2,145 | 2,147 |
Income After Depreciation & Amortization | 0 | 868 | 1,032 | 925 | 1,018 |
Non-Operating Income | NA | 21 | 13 | 10 | 11 |
Interest Expense | NA | 30 | 26 | 22 | 49 |
Pretax Income | NA | 859 | 1,019 | 912 | 979 |
Income Taxes | NA | 198 | 229 | 187 | 197 |
Minority Interest | NA | 0 | 0 | -1 | -2 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 737 | 661 | 790 | 726 | 782 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 737 | 661 | 790 | 726 | 784 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 1,388 | 1,556 | 1,432 | 1,499 |
Depreciation & Amortization (Cash Flow) | NA | 520 | 524 | 507 | 482 |
Income After Depreciation & Amortization | 0 | 868 | 1,032 | 925 | 1,018 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 1,488.37 | 1,501.89 | 1,513.32 | 1,513.43 | 1,513.38 |
Diluted EPS Before Non-Recurring Items | 0.50 | 0.44 | 0.53 | 0.48 | 0.52 |
Diluted Net EPS (GAAP) | 0.50 | 0.44 | 0.52 | 0.48 | 0.52 |
Fiscal Year end for Terumo Corp falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1,656.24 | NA | 1,619.03 | 1,582.29 | 1,571.34 |
Cost Of Goods | NA | NA | NA | NA | 769.81 |
Gross Profit | NA | NA | NA | NA | 801.53 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 585.12 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 216.41 |
Non-Operating Income | NA | NA | NA | NA | 4.41 |
Interest Expense | NA | NA | NA | NA | 3.24 |
Pretax Income | NA | NA | NA | NA | 217.57 |
Income Taxes | NA | NA | NA | NA | 52.95 |
Minority Interest | NA | NA | NA | NA | 0.00 |
Investment Gains/Losses | NA | NA | NA | NA | 0.00 |
Other Income/Charges | NA | NA | NA | NA | 0.00 |
Income From Cont. Operations | 217.40 | NA | 201.84 | 190.63 | 164.62 |
Extras & Discontinued Operations | 0.00 | NA | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 217.40 | NA | 201.84 | 190.63 | 164.61 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 1,485.15 | NA | 1,488.39 | 1,489.21 | 1,489.37 |
Diluted EPS Before Non-Recurring Items | 0.15 | NA | 0.14 | 0.13 | 0.11 |
Diluted Net EPS (GAAP) | 0.15 | NA | 0.14 | 0.13 | 0.11 |